Sequentia Biotech

Sequentia Biotech, an innovative bioinformatics firm, has been at the forefront of genomics since its establishment in 2013. Renowned for its cutting-edge solutions, Sequentia excels in providing comprehensive bioinformatics and software solutions across a spectrum of fields, including diagnostics, drug discovery, medical and academic research, plant biology, and food technologies. With a remarkable 15 years of experience in bioinformatics and significant investments in Research and Development (R&D), Sequentia has successfully completed over 700 bioinformatics projects. Serving clients in 63 countries, the company has contributed to over 70 publications in esteemed journals, showcasing an impressive H-index of 130. This outstanding track...

Biotechnology,bioinformatics,genetics,molecular biology,r&d,plant science,genomics,transcriptomics,epigenetics,scientific consulting,dna-protein interactions,microbiomics,metagenomics,and bioinformatics softwares

Sequentia biotech operates in the Biotechnology industry.

Sequentia biotech's revenue is 11m - 100m

Sequentia biotech has 11 - 50 employees.